Skip to main navigation
  • Newsroom
  • Get in Touch
  • LinkedIn
Editas Medicine logo
  • Research and Pipeline
  • CRISPR Gene Editing
  • For Patients
  • Who We Are
  • Join Our Team
  • Investors
  • Newsroom
  • Get in Touch
  • LinkedIn

Media & Investors

  • Overview
  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Documents & Charters
    • Management
    • Board of Directors
    • Committee Composition
    • Annual Meeting Materials
  • Financials & Filings
    • SEC Filings
    • Annual Reports
  • Stock Information
    • Stock Quote & Chart
  • Investor FAQs
  • Contact

Events & Presentations

Events & Presentations

Presentations
January 2023 Corporate Presentation
editasthumb
EDIT-301 Clinical Trial Update December 2022
EDIT-301 Clinical Trial Update December 2022 thumbnail
Past Events
Q4 2017 Editas Medicine Inc. Earnings Conference Call
Mar 6, 2018 at 5:00 PM EST
SunTrust Robinson Humphrey 4th Annual Orphan Drug Day
Feb 13, 2018 at 12:00 PM EST
SunTrust Robinson Humphrey 4th Annual Orphan Drug Day
Feb 13, 2018
BIO CEO & Investor Conference
Feb 12, 2018 at 1:30 PM EST
BIO CEO & Investor Conference
Feb 12, 2018 at 1:30 PM EST
Editas Medicine Inc. Q&A (J.P. Morgan Healthcare Conference)
Jan 10, 2018 at 9:00 AM PST
Editas Medicine Inc. Q&A (J.P. Morgan Healthcare Conference)
Jan 10, 2018 at 9:00 AM PST
Editas Medicine Inc. at J.P. Morgan Healthcare Conference
Jan 10, 2018 at 8:30 AM PST
Editas Medicine Inc. at J.P. Morgan Healthcare Conference
Jan 10, 2018 at 8:30 AM PST
Editas Medicine Inc. at Oppenheimer Orphan/Rare Disease Day
Dec 5, 2017 at 12:00 PM EST

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Current page 8
  • Page 9
  • Page 10
  • Page 11
  • Next page next ›
  • Last page last »

>> Main navigation

  • Research and Pipeline
  • CRISPR Gene Editing
  • For Patients
  • Who We Are
  • Join Our Team
  • Investors

©Copyright 2023 Editas Medicine

>> Footer menu

  • Get in Touch
  • Investors
  • Privacy Policy
  • Terms of Use